• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 重症监护病房幸存者的长期残疾。

Long-Term Disabilities in ICU Survivors of COVID-19.

机构信息

Departamento de Ciências do Movimento Humano, Universidade Federal de São Paulo, Santos, São Paulo, Brazil.

Serviço de Fisioterapia, Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.

出版信息

Respir Care. 2024 Nov 18;69(12):1508-1516. doi: 10.4187/respcare.12032.

DOI:10.4187/respcare.12032
PMID:39438066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11573000/
Abstract

BACKGROUND

COVID-19 is associated with prolonged disability, particularly after critical illness. This study aimed to assess and compare disability post-hospital discharge of subjects who were invasively ventilated versus those who were not, following ICU admission due to COVID-19. This study also explored variables associated with long-term disability.

METHODS

In this prospective cohort study, subjects with COVID-19 who received invasive ventilation, noninvasive ventilation, or high-flow nasal cannula during ICU stay were assessed with the World Health Organization Disability Assessment Schedule (WHODAS) 2.0 at 3 and 6 months post-hospital discharge. Data were analyzed collectively and stratified as subjects with and without invasive mechanical ventilation. Analysis of variance and multiple regression analyses were applied.

RESULTS

The subjects ( = 43) were mainly male, middle age, and overweight. Subjects who were invasively ventilated ( = 21) had decreased physical function compared to those who were not during hospital assessments. From 3-6 months after discharge, all WHODAS domains and the overall score decreased in both groups ( < .001), indicating disability recovery. The participation domain, which assesses joining in society, was the only domain that remained worse in the ventilation group compared to the no ventilation group ( = .01). No interaction was found between time and the study groups, suggesting that the recovery trajectory was similar. At 6 months, considering the entire cohort, 70% and 56% had no disability in self-care and getting along domains, respectively, while 42% exhibited moderate to severe disability in the participation domain. According to the overall WHODAS score, 86% of subjects still had some level of disability at 6 months. In multivariate analyses, the overall WHODAS score along with the household and participation domains showed significant positive correlations, indicating higher disability, with corticosteroid use.

CONCLUSIONS

Disability persisted at 6 month post-hospital discharge for ICU survivors of COVID-19, regardless of the need for invasive mechanical ventilation. Participation was the only domain that showed higher disability among those who received invasive ventilation.

摘要

背景

COVID-19 与长期残疾有关,尤其是在重症后。本研究旨在评估和比较因 COVID-19 入住 ICU 后接受有创通气和未接受有创通气的患者出院后的残疾情况。本研究还探讨了与长期残疾相关的变量。

方法

在这项前瞻性队列研究中,对接受有创通气、无创通气或高流量鼻导管通气的 COVID-19 患者,在出院后 3 个月和 6 个月时使用世界卫生组织残疾评估表(WHODAS)2.0 进行评估。对所有数据进行了综合分析,并按照有无有创机械通气进行了分层分析。应用方差分析和多元回归分析。

结果

患者(n=43)主要为男性、中年和超重。与未接受有创机械通气的患者相比,接受有创机械通气的患者(n=21)在住院评估时的身体功能下降。出院后 3-6 个月,两组患者的所有 WHODAS 领域和总体评分均下降(<0.001),表明残疾得到恢复。参与领域,即评估参与社会活动的能力,是通气组与无通气组相比唯一仍较差的领域(=0.01)。未发现时间与研究组之间存在交互作用,表明恢复轨迹相似。在 6 个月时,考虑整个队列,分别有 70%和 56%的患者在自我护理和相处领域无残疾,而 42%的患者在参与领域有中度至重度残疾。根据总体 WHODAS 评分,86%的患者在 6 个月时仍有一定程度的残疾。多元分析显示,WHODAS 总体评分以及家庭和参与领域与皮质类固醇的使用呈显著正相关,表明残疾程度更高。

结论

COVID-19 ICU 幸存者无论是否需要有创机械通气,在出院后 6 个月仍存在残疾。接受有创通气的患者中,只有参与领域显示出更高的残疾。

相似文献

1
Long-Term Disabilities in ICU Survivors of COVID-19.COVID-19 重症监护病房幸存者的长期残疾。
Respir Care. 2024 Nov 18;69(12):1508-1516. doi: 10.4187/respcare.12032.
2
Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit.对重症监护病房中的成年重症患者进行早期干预(活动或主动锻炼)。
Cochrane Database Syst Rev. 2018 Mar 27;3(3):CD010754. doi: 10.1002/14651858.CD010754.pub2.
3
Early versus late tracheostomy in critically ill COVID-19 patients.危重症 COVID-19 患者的早期与晚期气管切开术。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD015532. doi: 10.1002/14651858.CD015532.
4
Melatonin for the promotion of sleep in adults in the intensive care unit.褪黑素用于促进重症监护病房成年患者的睡眠。
Cochrane Database Syst Rev. 2018 May 10;5(5):CD012455. doi: 10.1002/14651858.CD012455.pub2.
5
Non-pharmacological interventions for sleep promotion in hospitalized children.促进住院儿童睡眠的非药物干预措施。
Cochrane Database Syst Rev. 2022 Jun 15;6(6):CD012908. doi: 10.1002/14651858.CD012908.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.无创通气用于治疗慢性阻塞性肺疾病急性加重所致的急性高碳酸血症性呼吸衰竭。
Cochrane Database Syst Rev. 2017 Jul 13;7(7):CD004104. doi: 10.1002/14651858.CD004104.pub4.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) for the diagnosis of delirium in adults in critical care settings.**用于** ICU 成人患者的意识模糊评估方法(CAM-ICU)**用于** 诊断重症监护环境下成人的意识障碍。
Cochrane Database Syst Rev. 2023 Nov 21;11(11):CD013126. doi: 10.1002/14651858.CD013126.pub2.
10
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.

引用本文的文献

1
Disability Following Critical Illness Due to COVID-19-Where to Next?COVID-19导致的危重症后的残疾——何去何从?
Respir Care. 2024 Nov 18;69(12):1614-1616. doi: 10.4187/respcare.12605.

本文引用的文献

1
A comprehensive physical functional assessment of survivors of critical care unit stay due to COVID-19.因 COVID-19 而入住重症监护病房的幸存者的全面身体功能评估。
Crit Care Sci. 2024 May 3;36:e20240284en. doi: 10.62675/2965-2774.20240284-en. eCollection 2024.
2
Mental, cognitive and physical outcomes after intensive care unit treatment during the COVID-19 pandemic: a comparison between COVID-19 and non-COVID-19 patients.COVID-19 大流行期间重症监护病房治疗后的心理、认知和身体结局:COVID-19 患者与非 COVID-19 患者的比较。
Sci Rep. 2023 Sep 2;13(1):14414. doi: 10.1038/s41598-023-41667-4.
3
Long-term outcomes of COVID-19 intensive care unit survivors and their family members: a one year follow-up prospective study.COVID-19 重症监护病房幸存者及其家属的长期结局:一项为期一年的前瞻性随访研究。
Front Public Health. 2023 Aug 8;11:1236990. doi: 10.3389/fpubh.2023.1236990. eCollection 2023.
4
Long COVID-unravelling a complex condition.长期新冠——剖析一种复杂病症。
Lancet Respir Med. 2023 Aug;11(8):667-668. doi: 10.1016/S2213-2600(23)00232-1. Epub 2023 Jul 17.
5
Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations.COVID-19 的急性后期后遗症:理解和应对多系统表现的负担。
Lancet Respir Med. 2023 Aug;11(8):739-754. doi: 10.1016/S2213-2600(23)00239-4. Epub 2023 Jul 17.
6
Post-intensive care syndrome and pulmonary fibrosis in patients surviving ARDS-pneumonia of COVID-19 and non-COVID-19 etiologies.COVID-19 和非 COVID-19 病因导致的 ARDS-肺炎存活患者的重症监护后综合征和肺纤维化。
Sci Rep. 2023 Apr 21;13(1):6554. doi: 10.1038/s41598-023-32699-x.
7
Association between prolonged corticosteroids use in COVID-19 and increased mortality in hospitalized patients: a retrospective study with inverse probability of treatment weighting analysis.COVID-19 患者中长期使用皮质类固醇与住院患者死亡率增加的关联:一项采用逆概率治疗加权分析的回顾性研究。
Crit Care. 2023 Apr 15;27(1):143. doi: 10.1186/s13054-023-04434-5.
8
Long COVID: 3 years in.新冠长期症状:三年过去了。
Lancet. 2023 Mar 11;401(10379):795. doi: 10.1016/S0140-6736(23)00493-2.
9
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.REMAP-CAP 随机临床试验中 COVID-19 危重症患者的长期(180 天)结局。
JAMA. 2023 Jan 3;329(1):39-51. doi: 10.1001/jama.2022.23257.
10
Twelve Months and Counting: Following Clinical Outcomes in Critical COVID-19 Survivors.十二个月过去了:重症 COVID-19 幸存者的临床结局观察。
Ann Am Thorac Soc. 2023 Feb;20(2):289-295. doi: 10.1513/AnnalsATS.202207-630OC.